Дебиторская задолженность Изменить Дата
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
Arrowhead Research USD 15.68M 203.19M 2026-03
Astellas Pharma JPY 761.76B 48.47B 2026-03
BioCryst Pharmaceuticals USD 106.82M 15.49M 2025-12
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Celltrion KRW 2.01T 39.71B 2026-03
Cspc Pharmaceutical CNY 8.79B 64.64M 2025-12
Deva Holding AS TRY 3.03B 343.23M 2023-09
Divis Laboratories Ltd INR 29.99B 3.71B 2026-03
Exelixis USD 328.95M 42.03M 2026-03
Halozyme Therapeutics USD 457.99M 16.72M 2026-03
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
Kangmei Pharma CNY 2.92B 228.09M 2026-03
Knight Therapeutics CAD 183M 7.46M 2025-12
Laboratorios Farma EUR 143.38M 16.93M 2023-12
Malin Corporation EUR 500K 300K 2024-12
Medical Developments International AUD 7.48M 174K 2025-12
Moderna USD 17M 54M 2026-06
Nektar Therapeutics USD 3.6M 1.82M 2026-03
Neuren Pharmaceuticals AUD 26.54M 5.83M 2025-12
Neurocrine Biosciences USD 887M 118.9M 2026-06
Novartis USD 9.85B 252M 2026-06
Omeros USD 8.08M 440K 2024-06
OPKO Health USD 107.62M 18.49M 2026-03
Organigram Holdings CAD 53.39M 3.45M 2026-03
Ovoca Bio EUR 53K 14K 2025-12
Pfizer USD 16.19B 19M 2026-06
Pharma Mar EUR 58.06M 6.87M 2026-06
PTC Therapeutics USD 219.92M 38.3M 2026-03
Qiagen NV USD 396.62M 5.99M 2026-03
Regeneron Pharmaceuticals USD 6.57B 834.4M 2026-06
Roche Holding CHF 13.34B 1.44B 2026-06
Sarepta Therapeutics USD 547.91M 149.68M 2026-03
Sartorius EUR 381.2M 14.6M 2026-06
Sino Biopharmaceutical CNY 8.45B 3.18B 2025-06
Tilray USD 109.07M 2M 2025-09
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
Vertex Pharmaceuticals USD 2.13B 138.2M 2026-06
Zealand Pharma A/S 259M 81M 2026-03
Zz Pientze Pharmaceu CNY 1.06B 60.42M 2026-03